Pharmaceutical Supply and Distribution

The contract entails the supply and delivery of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 mL, identified by NSN 6505001387347, with a total quantity of 13,000 units distributed across multiple CLINs to military medical facilities. The product must be packaged and labeled in full compliance with U.S. Pharmacopeia standards and all applicable federal regulations, ensuring traceability, safety, and regulatory alignment for use in military healthcare settings. Delivery is specified as FOB Destination, meaning the contractor assumes full responsibility for transit risks and logistics until the shipment arrives at the designated military medical locations, with the primary place of performance listed as Hampton, Virginia, 23665-2040. This is a subcontract under the Department of Defense’s Medical Supply Chain PHARM FSA, classified under NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on July 14, 2026, with responses required by July 20, 2026, indicating a tight turnaround for qualified suppliers. The contract does not specify a set-aside type, suggesting it is open to general industry competition. All deliveries must meet military-grade quality and documentation requirements, and the contractor is expected to manage inventory, packaging, labeling, and timely fulfillment to support the operational readiness of military medical units.